title: [Rotavirus vaccination in Europe in 2010].
abstract: The important burden of rotavirus infections in infants largely justifies vaccine prevention. Two attenuated oral vaccines were licensed in Europe in 2006 and have proven effective against severe rotavirus gastroenteritis in infants, yet few countries have implemented vaccination. This hesitation may be related to a very low risk of intussusception in vaccinees, but is mainly due to national differences in cost-effectiveness.
authors: Hôpital Trousseau, 26, avenue du Docteur Arnold Netter, 75012 Paris. emmanuel.grimprel@trs.aphp.fr
authors: Emmanuel
authors: E
authors: Grimprel
mesh_terms: D005060:Europe / Q000453:epidemiology; D006801:Humans; D007223:Infant; D007226:Infant Mortality / Q000639:trends; D007231:Infant, Newborn; D012401:Rotavirus / Q000276:immunology*; D012400:Rotavirus Infections / Q000453:epidemiology / Q000276:immunology / Q000401:mortality / Q000517:prevention & control*; D022243:Rotavirus Vaccines / Q000009:adverse effects / Q000627:therapeutic use*; D013997:Time Factors; D014611:Vaccination / Q000009:adverse effects / Q000191:economics / Q000379:methods / Q000706:statistics & numerical data
chemical_list: D022243:Rotavirus Vaccines